Cargando…

Local Immune Regulation of Mucosal Inflammation by Tacrolimus

PURPOSE: Tacrolimus is a potent immunomodulator that is effective in the treatment of inflammatory bowel disease (IBD). However, potential toxicity and systemic effects with oral intake limit its use. Local tacrolimus treatment is effective in a subgroup of proctitis patients. This study aimed to ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Dieren, Jolanda M., Lambers, Margaretha E. H., Kuipers, Ernst J., Samsom, Janneke N., van der Woude, C. Janneke, Nieuwenhuis, Edward E. S.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer US 2009
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914281/ https://www.ncbi.nlm.nih.gov/pubmed/19949865 http://dx.doi.org/10.1007/s10620-009-1047-2

Ejemplares similares

Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD
por: Tindemans, Irma, et al.
Publicado: (2020)

Peripheral Neutrophil Functions and Cell Signalling in Crohn`s Disease
por: Somasundaram, Rajesh, et al.
Publicado: (2013)

Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation
por: Sleutjes, Jasmijn A M, et al.
Publicado: (2022)

Systemic tacrolimus in the treatment of recalcitrant mucosal lichen planus
por: Chen, Edward, et al.
Publicado: (2017)

Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease
por: Deuring, J. Jasper, et al.
Publicado: (2019)

The impact of biologics on health-related quality of life in patients with inflammatory bowel disease
por: Vogelaar, Lauran, et al.
Publicado: (2009)

Gene Expression Analysis of Peripheral Cells for Subclassification of Pediatric Inflammatory Bowel Disease in Remission
por: van Lierop, Pieter P. E., et al.
Publicado: (2013)

Intestinal Regulatory T Cells as Specialized Tissue-Restricted Immune Cells in Intestinal Immune Homeostasis and Disease
por: Jacobse, Justin, et al.
Publicado: (2021)

Response to “Cytomegalovirus Enterocolitis in a Patient with Refractory Immune-Related Colitis”
por: van Turenhout, Sietze, et al.
Publicado: (2021)

Fatigue in patients with inflammatory bowel disease is associated with distinct differences in immune parameters
por: Vogelaar, Lauran, et al.
Publicado: (2017)

Small bowel Crohn’s disease: MR enteroclysis and capsule endoscopy compared to balloon-assisted enteroscopy
por: Wiarda, Bart M., et al.
Publicado: (2011)

Integrating succession and community assembly perspectives
por: Chang, Cynthia, et al.
Publicado: (2016)

Patient sex does not affect endoscopic outcomes of biologicals in inflammatory bowel disease but is associated with adverse events
por: Lie, Mitchell R. K. L., et al.
Publicado: (2020)

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study
por: Paulides, Emma, et al.
Publicado: (2022)

A Direct Effect of Sex Hormones on Epithelial Barrier Function in Inflammatory Bowel Disease Models
por: van der Giessen, Janine, et al.
Publicado: (2019)

Modulatory Effects of Pregnancy on Inflammatory Bowel Disease
por: van der Giessen, Janine, et al.
Publicado: (2019)

Climate Warming and Seasonal Precipitation Change Interact to Limit Species Distribution Shifts across Western North America
por: Harsch, Melanie A., et al.
Publicado: (2016)

Intestinal resection rates in Crohn’s disease decline across two different epidemiological areas: a consistent observation not merely due to introduction of anti-TNFα
por: Beelen, Evelien M J, et al.
Publicado: (2020)

Fecal calprotectin is a reliable marker of endoscopic response to vedolizumab therapy: A simple algorithm for clinical practice
por: Pauwels, Renske Wilhelmina Maria, et al.
Publicado: (2020)

Inflammatory bowel disease negatively impacts household and family life
por: Paulides, Emma, et al.
Publicado: (2021)

Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management
por: Sleutjes, Jasmijn A. M., et al.
Publicado: (2021)

The Effect of Psychotherapy on Quality of Life in IBD Patients: A Systematic Review
por: Paulides, Emma, et al.
Publicado: (2020)

Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case–control study
por: Gerrits, Monique M., et al.
Publicado: (2011)

Changes in Natural Foxp3(+)Treg but Not Mucosally-Imprinted CD62L(neg)CD38(+)Foxp3(+)Treg in the Circulation of Celiac Disease Patients
por: van Leeuwen, Marieke A., et al.
Publicado: (2013)

Analysis of SHIP1 expression and activity in Crohn’s disease patients
por: Somasundaram, Rajesh, et al.
Publicado: (2017)

Immune system in the intestine and mucosal inflammation
por: O'Mahony, Liam
Publicado: (2011)

Mediators of Gut Mucosal Immunity and Inflammation
por: Tekin, Ishak Ozel, et al.
Publicado: (2015)

Human γδ T-Cell Control of Mucosal Immunity and Inflammation
por: McCarthy, Neil E., et al.
Publicado: (2018)

Does lower gastrointestinal endoscopy during pregnancy pose a risk for mother and child? – a systematic review
por: De Lima, Alison, et al.
Publicado: (2015)

Comparative Genomics and Physiology of Akkermansia muciniphila Isolates from Human Intestine Reveal Specialized Mucosal Adaptation
por: Ouwerkerk, Janneke P., et al.
Publicado: (2022)

Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease
por: Pauwels, Renske W M, et al.
Publicado: (2021)

Treatment of refractory juvenile dermatomyositis with tacrolimus
por: Hassan, J, et al.
Publicado: (2008)

Serum Immune Profiling in Paediatric Crohn’s Disease Demonstrates Stronger Immune Modulation With First-Line Infliximab Than Conventional Therapy and Pre-Treatment Profiles Predict Clinical Response to Both Treatments
por: Jongsma, Maria M E, et al.
Publicado: (2023)

Health Care Transition Outcomes in Inflammatory Bowel Disease: A Multinational Delphi Study
por: van den Brink, Gertrude, et al.
Publicado: (2019)

Editorial: Oral mucosal immunity: homeostasis and inflammation
por: Zhang, Dunfang, et al.
Publicado: (2023)

‘Natural experiment’ Demonstrates Top-Down Control of Spiders by Birds on a Landscape Level
por: Rogers, Haldre, et al.
Publicado: (2012)

Correction: ‘Natural experiment’ Demonstrates Top-Down Control of Spiders by Birds on a Landscape Level
por: Rogers, Haldre, et al.
Publicado: (2013)

Serum Markers and Intestinal Mucosal Injury in Chronic Gastrointestinal Ischemia
por: van Noord, Désirée, et al.
Publicado: (2010)

Digital Outcome Measurement to Improve Care for Patients With Immune-Mediated Inflammatory Diseases: Protocol for the IMID Registry
por: Looijen, Agnes E M, et al.
Publicado: (2023)

High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23
por: Dahlerup, Jens Frederik, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cnte8jji6h566nut7j2ohodgig